Pankaj Singh to Pancreatic Neoplasms
This is a "connection" page, showing publications Pankaj Singh has written about Pancreatic Neoplasms.
Connection Strength
12.253
-
The MUC1-HIF-1a signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Proc Natl Acad Sci U S A. 2024 Apr 02; 121(14):e2315509121.
Score: 0.598
-
Metabolomic Investigations into Hypoxia-Mediated Metabolic Reprogramming of Pancreatic Cancer Cells. Methods Mol Biol. 2024; 2755:191-200.
Score: 0.588
-
ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer. Cancer Lett. 2023 01 01; 552:215981.
Score: 0.542
-
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Gastroenterology. 2021 11; 161(5):1584-1600.
Score: 0.495
-
Molecular Subtypes of Pancreatic Cancer: A Proteomics Approach. Clin Cancer Res. 2021 06 15; 27(12):3272-3274.
Score: 0.487
-
JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia. Cancer Lett. 2020 10 28; 491:70-77.
Score: 0.464
-
MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism. Oncogene. 2020 04; 39(16):3381-3395.
Score: 0.450
-
Metabolic Subtyping for Novel Personalized Therapies Against Pancreatic Cancer. Clin Cancer Res. 2020 01 01; 26(1):6-8.
Score: 0.439
-
Evaluating the Metabolic Alterations in Pancreatic Cancer. Methods Mol Biol. 2019; 1882:221-228.
Score: 0.416
-
Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia. Methods Mol Biol. 2019; 1882:321-333.
Score: 0.416
-
Microscale Gene Expression Analysis of Tumor-Associated Macrophages. Sci Rep. 2018 02 05; 8(1):2408.
Score: 0.390
-
Evaluating the Metabolic Impact of Hypoxia on Pancreatic Cancer Cells. Methods Mol Biol. 2018; 1742:81-93.
Score: 0.388
-
Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells. Methods Mol Biol. 2018; 1742:95-105.
Score: 0.388
-
Hypoxia-Mediated In Vivo Tumor Glucose Uptake Measurement and Analysis. Methods Mol Biol. 2018; 1742:107-113.
Score: 0.388
-
Evaluation of Macrophage Polarization in Pancreatic Cancer Microenvironment Under Hypoxia. Methods Mol Biol. 2018; 1742:265-276.
Score: 0.388
-
De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Cancer Res. 2017 10 15; 77(20):5503-5517.
Score: 0.378
-
MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Clin Cancer Res. 2017 Oct 01; 23(19):5881-5891.
Score: 0.376
-
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell. 2017 07 10; 32(1):71-87.e7.
Score: 0.375
-
GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells. Cancer Lett. 2017 08 01; 400:37-46.
Score: 0.370
-
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget. 2015 Dec 01; 6(38):41146-61.
Score: 0.336
-
MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Oncotarget. 2015 Aug 07; 6(22):19118-31.
Score: 0.328
-
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer. Proc Natl Acad Sci U S A. 2012 Aug 21; 109(34):13787-92.
Score: 0.267
-
MicroRNAs in pancreatic cancer metabolism. Nat Rev Gastroenterol Hepatol. 2012 Apr 17; 9(6):334-44.
Score: 0.261
-
Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma. PLoS One. 2012; 7(3):e32996.
Score: 0.259
-
Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells. Cancer Res. 2007 Jun 01; 67(11):5201-10.
Score: 0.186
-
MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer. Oncogene. 2022 07; 41(31):3859-3875.
Score: 0.132
-
Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer. Cancer Res. 2022 06 15; 82(12):2254-2268.
Score: 0.132
-
The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates KRAS expression in pancreatic ductal adenocarcinoma cells. Nucleic Acids Res. 2022 04 08; 50(6):3394-3412.
Score: 0.130
-
Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling. Sci Rep. 2022 01 31; 12(1):1659.
Score: 0.129
-
Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer. Cancer Res. 2021 08 01; 81(15):4001-4013.
Score: 0.122
-
Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2. Gastroenterology. 2020 11; 159(5):1866-1881.e8.
Score: 0.116
-
SIRT1-NOX4 signaling axis regulates cancer cachexia. J Exp Med. 2020 07 06; 217(7).
Score: 0.115
-
Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal. Biochim Biophys Acta Rev Cancer. 2020 08; 1874(1):188387.
Score: 0.115
-
Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Cancer Lett. 2020 08 01; 484:29-39.
Score: 0.114
-
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2019 04; 25(4):628-640.
Score: 0.105
-
Insights into gemcitabine resistance and the potential for therapeutic monitoring. Metabolomics. 2018 11 27; 14(12):156.
Score: 0.103
-
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. Cancer Immunol Immunother. 2018 Mar; 67(3):445-457.
Score: 0.096
-
Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells. J Proteome Res. 2017 10 06; 16(10):3536-3546.
Score: 0.095
-
Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer. Br J Pharmacol. 2016 Dec; 173(23):3292-3306.
Score: 0.089
-
EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer. Biomacromolecules. 2016 Jan 11; 17(1):301-13.
Score: 0.084
-
Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3. Oncotarget. 2015 Nov 03; 6(34):36019-31.
Score: 0.083
-
Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancer. Biochemistry. 2014 Mar 04; 53(8):1360-72.
Score: 0.074
-
Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Clin Cancer Res. 2012 Nov 15; 18(22):6188-98.
Score: 0.067
-
Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Lett. 2012 Oct 01; 323(1):29-40.
Score: 0.065
-
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras. Clin Cancer Res. 2011 Oct 01; 17(19):6140-50.
Score: 0.062
-
The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene. 2010 Oct 21; 29(42):5667-77.
Score: 0.058
-
Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res. 2008 Oct 01; 14(19):5995-6004.
Score: 0.051
-
MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Res. 2008 Apr 01; 68(7):2065-70.
Score: 0.049
-
MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion. Cancer Res. 2007 Nov 01; 67(21):10222-9.
Score: 0.048
-
RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells. Clin Cancer Res. 2006 May 15; 12(10):2976-87.
Score: 0.043